Of course I am long and hope the stock goes up in price. Additionally, the conference and presentations were excellent and the analysts are taking notice and will put buy ratings on the stock. What are your thoughts??
1. Nothing new has been reported that wasn't previously known.
2. India is a huge problem. You can't go back and exclude trial results that you don't like. The FDA will say, that's very interesting and if you conduct a new trial that supports your hypothesis, we'll approve it. They aren't going to approve a drug based on a botched trial.